Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

FDA Approves Adjuvant Atezolizumab for Certain Colon Cancers

(MedPage Today) -- The FDA on Thursday approved intravenous atezolizumab (Tecentriq) in combination with a fluoropyrimidine and oxaliplatin for the adjuvant treatment of stage III mismatch repair-deficient (dMMR) colon cancer in patients 2 years...

FDA Approves Adjuvant Atezolizumab for Certain Colon Cancers

We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.

Read the original at medpagetoday.com →

More in Health & Medicine

More from Friday 9 October →